Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer.

Sachdev D, Yee D.

J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):27-39. Review.

PMID:
16947084
2.

Targeting insulin-like growth factor in breast cancer therapeutics.

Karamouzis MV, Papavassiliou AG.

Crit Rev Oncol Hematol. 2012 Oct;84(1):8-17. doi: 10.1016/j.critrevonc.2012.02.010. Epub 2012 Mar 15. Review.

PMID:
22424863
3.

Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.

You L, Liu C, Tang H, Liao Y, Fu S.

Curr Pharm Des. 2014;20(17):2899-911. Review.

PMID:
23944362
4.

IGF-1 receptor inhibitors in clinical trials--early lessons.

Weroha SJ, Haluska P.

J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):471-83. doi: 10.1007/s10911-008-9104-6. Epub 2008 Nov 21. Review.

5.

Targeting insulin-like growth factor type 1 receptor in cancer therapy.

Atzori F, Traina TA, Ionta MT, Massidda B.

Target Oncol. 2009 Dec;4(4):255-66. doi: 10.1007/s11523-009-0123-z. Epub 2009 Oct 30. Review.

PMID:
19876700
6.

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives.

Xue M, Cao X, Zhong Y, Kuang D, Liu X, Zhao Z, Li H.

Curr Pharm Des. 2012;18(20):2901-13. Review.

PMID:
22571659
7.

IGF-1R as an anti-cancer target--trials and tribulations.

Chen HX, Sharon E.

Chin J Cancer. 2013 May;32(5):242-52. doi: 10.5732/cjc.012.10263. Epub 2013 Apr 19. Review.

8.
9.

Targeted therapy of the insulin-like growth factor-1 receptor in cancer.

Paz K, Hadari YR.

Comb Chem High Throughput Screen. 2008 Jan;11(1):62-9. Review.

PMID:
18220543
10.

Insulin-Like Growth Factor (IGF) family and prostate cancer.

Gennigens C, Menetrier-Caux C, Droz JP.

Crit Rev Oncol Hematol. 2006 May;58(2):124-45. Epub 2006 Jan 18. Review.

PMID:
16387509
11.

The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma.

Ewing GP, Goff LW.

Clin Colorectal Cancer. 2010 Oct;9(4):219-23. doi: 10.3816/CCC.2010.n.032. Review.

PMID:
20920993
12.

Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine.

Hewish M, Chau I, Cunningham D.

Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):54-72. Review.

PMID:
19149688
13.

Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.

Iams WT, Lovly CM.

Clin Cancer Res. 2015 Oct 1;21(19):4270-7. doi: 10.1158/1078-0432.CCR-14-2518. Review.

14.

The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.

Heidegger I, Massoner P, Sampson N, Klocker H.

Cancer Lett. 2015 Oct 28;367(2):113-21. doi: 10.1016/j.canlet.2015.07.026. Epub 2015 Jul 29. Review.

PMID:
26231734
15.

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

King H, Aleksic T, Haluska P, Macaulay VM.

Cancer Treat Rev. 2014 Oct;40(9):1096-105. doi: 10.1016/j.ctrv.2014.07.004. Epub 2014 Aug 4. Review.

16.

Role of insulin-like growth factor-1R system in colorectal carcinogenesis.

Donovan EA, Kummar S.

Crit Rev Oncol Hematol. 2008 May;66(2):91-8. Epub 2007 Oct 31. Review.

17.

The insulin-like growth factor 1 receptor in cancer: old focus, new future.

Hartog H, Wesseling J, Boezen HM, van der Graaf WT.

Eur J Cancer. 2007 Sep;43(13):1895-904. Epub 2007 Jul 10. Review.

PMID:
17624760
18.

Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?

Gombos A, Metzger-Filho O, Dal Lago L, Awada-Hussein A.

Invest New Drugs. 2012 Dec;30(6):2433-42. doi: 10.1007/s10637-012-9811-0. Epub 2012 Mar 14. Review.

19.

Novel mechanisms of regulation of IGF-1R action: functional and therapeutic implications.

Worrall C, Nedelcu D, Serly J, Suleymanova N, Oprea I, Girnita A, Girnita L.

Pediatr Endocrinol Rev. 2013 Jul;10(4):473-84. Review.

PMID:
23957198
20.

The insulin-like growth factor pathway as a target for cancer therapy.

López-Calderero I, Sánchez Chávez E, García-Carbonero R.

Clin Transl Oncol. 2010 May;12(5):326-38. doi: 10.1007/s12094-010-0514-8. Review.

PMID:
20466617

Supplemental Content

Support Center